Meningioma 1 Antikörper
Kurzübersicht für Meningioma 1 Antikörper (ABIN7116478)
Target
Alle Meningioma 1 (MN1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- MN1 antibody
-
Aufreinigung
- Immunogen affinity purified
-
Reinheit
- ≥95 % as determined by SDS-PAGE
-
Immunogen
- meningioma(disrupted in balanced translocation) 1
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- IHC: 1:20-1:200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- PBS with 0.02 % sodium azide and 50 % glycerol pH 7.3,
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze / thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- -20°C for 12 months
-
Haltbarkeit
- 12 months
-
-
- Meningioma 1 (MN1) (MN1 proto-oncogene (MN1))
-
Andere Bezeichnung
- MN1
-
Hintergrund
-
Synonyms: Transcriptional activator MN1|Probable tumor suppressor protein MN1|MN1
Background: Transcriptional activator which specifically regulates expression of TBX22 in the posterior region of the developing palate. Required during later stages of palate development for growth and medial fusion of the palatal shelves. Promotes maturation and normal function of calvarial osteoblasts, including expression of the osteoclastogenic cytokine TNFSF11/RANKL. Necessary for normal development of the membranous bones of the skull(By similarity). May play a role in tumor suppression(Probable).
-
Gen-ID
- 4330
-
UniProt
- Q10571
Target
-